Global Neurological Biomarkers Market By Type (Genomics Biomarker, Proteomics Biomarker, Metabolomics Biomarkers, Imaging Biomarkers, and Others), By Application (Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, and Spinal Muscular Atrophy), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028
- Published date: Jun 2022
- Report ID: 36013
- Number of Pages: 380
- Format:
- keyboard_arrow_up
The report on Neurological Biomarkers Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global neurological biomarkers Market is segmented on the basis of type, application, and geography.
The worldwide market for Neurological Biomarkers Market is expected to grow at a CAGR of roughly 5.1 % over the next nine years, and will reach US$ 10,100.2 Mn in 2028, from US$ 6,141.9 Mn in 2018, according to a new Market.us (Prudour Research) study.
Neurological Biomarkers Market Scope:
By type, the market is segmented into Genomics Biomarker Proteomics Biomarker Metabolomics Biomarkers Imaging Biomarkers and Others. By application, the market is divided into Alzheimer’s Disease Parkinson’s Disease Huntington’s Disease Schizophrenia Depression Multiple Sclerosis and Spinal Muscular Atrophy.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Quanterix, Myriad RBM, QIAGEN, ADx NeuroSciences NV, Merck KGaA, Euroimmun, Thermo Fisher Scientific, BioCrypton, ACOBIOM, Banyan Biomarkers Inc., Olink Biosciences, and BioAgilytix.
trending_up Total Revenue in 2018$ 6,141.9 Mn
trending_up Market CAGR of the Next Ten Years5.1%
no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.- By Type
- By Region
- By Application
no_encryption Leading Companies Financial HighlightsPurchase this report or a membership to unlock the leading companies financial highlights for this industry.trending_up Market Revenue of the Next Ten Years$ 10,100.2 Mn
Key Market Segments
Type
- Genomics Biomarker
- Proteomics Biomarker
- Metabolomics Biomarkers
- Imaging Biomarkers
- Others
Application
- Alzheimer’s Disease
- Parkinson’s Disease
- Huntington’s Disease
- Schizophrenia
- Depression
- Multiple Sclerosis
- Spinal Muscular Atrophy
Key Market Players included in the report:
- Quanterix
- Myriad RBM
- QIAGEN
- ADx NeuroSciences NV
- Merck KGaA
- Euroimmun
- Thermo Fisher Scientific
- BioCrypton
- ACOBIOM
- Banyan Biomarkers Inc.
- Olink Biosciences
- BioAgilytix
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Neurological Biomarkers Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Neurological Biomarkers Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Neurological Biomarkers Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Neurological Biomarkers Market across sections such as also application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Neurological Biomarkers Market together side their company profiles, SWOT analysis, latest advancements, and business plans.
The analysis objectives of the report are:
- To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
- To know the Neurological Biomarkers Market by pinpointing its many subsegments.
- To profile the important players and analyze their growth plans.
- To endeavor the amount and value of Neurological Biomarkers Market sub-markets, depending on key regions (various vital states).
- To analyze Neurological Biomarkers Market concerning growth trends, prospects, and also their participation in the entire sector.
- To examine and study the Neurological Biomarkers Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2014 to 2019, and also prediction to 2028.
- Primary worldwide Neurological Biomarkers Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
- To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.
For the Neurological Biomarkers Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
![Neurological Biomarkers Market]( "Neurological Biomarkers Market")
Neurological Biomarkers MarketPublished date: Jun 2022add_shopping_cartBuy Now get_appDownload Sample - Quanterix
- Myriad RBM
- QIAGEN NV Company Profile
- ADx NeuroSciences NV
- Merck KGaA Company Profile
- Euroimmun
- Thermo Fisher Scientific Company Profile
- BioCrypton
- ACOBIOM
- Banyan Biomarkers Inc.
- Olink Biosciences
- BioAgilytix
- settingsSettings
Our Clients
- 36013
- Jun 2022
-
US $5,999US $2,999
-
US $7,999US $3,499
-
US $12,999US $4,499
|
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
|---|---|---|---|
| e-Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |
